SUGAMMADEX (Bridion®)
Clinical Indication
Reversal of neuromuscular blockage induced by rocuronium or vecuronium
Date of classification
May 2021
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.